Skip to main content
HOWL
NASDAQ Life Sciences

RA Capital Reduces Stake Below 5% in Werewolf Therapeutics

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.33
Mkt Cap
$16.542M
52W Low
$0.27
52W High
$2.38
52W Position info
22% above low
Off High info
86% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

HOWL sits 22% above its 52-week low of $0.27.

Summary

Major institutional investor RA Capital Management sold an additional $316,000 in Werewolf Therapeutics stock, reducing its stake below the 5% reporting threshold.


Key Events · Ownership and Investor Activity · HOWL

  • Significant Share Sales

    RA Capital Management sold approximately 936,543 shares for a total value of about $316,247 between June 29 and July 2, 2026.

  • Ownership Below 5% Threshold

    As a result of these sales, RA Capital Management ceased to be a beneficial owner of more than 5% of Werewolf Therapeutics' common stock as of June 30, 2026.

  • Continued Institutional Distribution

    This filing extends a recent trend of institutional investors, including RA Capital, reducing their positions in the company, with net insider sales of nearly $2 million over the last 90 days.


Analysis · HOWL · Life Sciences

RA Capital Management, a significant institutional investor, has further reduced its holdings in Werewolf Therapeutics, selling approximately $316,000 worth of shares. This latest round of sales caused the firm to drop below the 5% beneficial ownership threshold as of June 30, 2026, signaling a continued reduction in their investment in the company. This follows a pattern of distribution by institutional investors over the past 90 days.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 47.3% of the 1873 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, HOWL was trading at $0.33 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $16.5M. The 52-week trading range was $0.27 to $2.38. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

HOWL - Latest Insights

HOWL
Nov 13, 2026, 4:06 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $0.9836
Real-time Price: $0.9836 info
Change: $0 (0%) info
Market Cap: $47.642M info
HOWL
Nov 10, 2026, 4:37 PM EST
Filing Type: S-4/A
Importance Score:
8
Price at Filing: $0.970
Real-time Price: $0.9836 info
Change: +$0.0136 (+1%) info
Market Cap: $47.642M info
HOWL
Nov 09, 2026, 9:22 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.00
Real-time Price: $0.9836 info
Change: -$0.0164 (-2%) info
Market Cap: $47.642M info
HOWL
Oct 26, 2026, 5:23 PM EDT
Filing Type: S-4/A
Importance Score:
8
Price at Filing: $0.9806
Real-time Price: $0.9836 info
Change: +$0.0030 (+0.31%) info
Market Cap: $47.642M info
HOWL
Sep 22, 2026, 5:04 PM EDT
Filing Type: S-4
Importance Score:
9
Price at Filing: $0.9707
Real-time Price: $0.9836 info
Change: +$0.0129 (+1%) info
Market Cap: $47.642M info